|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2015. CA Cancer J Clin. 65:5–29. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Yuan X, Wu H, Han N, Xu H, Chu Q, Yu S,
Chen Y and Wu K: Notch signaling and EMT in non-small cell lung
cancer: Biological significance and therapeutic application. J
Hematol Oncol. 7:872014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Baumgart A, Mazur P, Anton M, Rudelius M,
Schwamborn K, Feuchtinger A, Behnke K, Walch A, Braren R, Peschel
C, et al: Opposing role of Notch1 and Notch2 in a Kras(G12D)-driven
murine non-small cell lung cancer model. Oncogene. 34:578–588.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Coffelt SB, Hughes R and Lewis CE:
Tumor-associated macrophages: Effectors of angiogenesis and tumor
progression. Biochimica et Biophysica Acta (BBA)-Reviews on Cancer.
1796:11–18. 2009. View Article : Google Scholar
|
|
5
|
Honda K and Taniguchi T: IRFs: Master
regulators of signalling by Toll-like receptors and cytosolic
pattern-recognition receptors. Nat Rev Immunol. 6:644–658. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Mamane Y, Heylbroeck C, Génin P, Algarté
M, Servant MJ, LePage C, DeLuca C, Kwon H, Lin R and Hiscott J:
Interferon regulatory factors: The next generation. Gene. 237:1–14.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Taniguchi T, Ogasawara K, Takaoka A and
Tanaka N: IRF family of transcription factors as regulators of host
defense. Annual Rev immunol. 19:623–655. 2001. View Article : Google Scholar
|
|
8
|
Wang L and Ning S: Interferon regulatory
factor 4 is activated through c-Src-mediated tyrosine
phosphorylation in virus-transformed cells. J Virol. 87:9672–9679.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Spender LC, Lucchesi W, Bodelon G,
Bilancio A, Karstegl CE, Asano T, Dittrich-Breiholz O, Kracht M,
Vanhaesebroeck B and Farrell PJ: Cell target genes of Epstein-Barr
virus transcription factor EBNA-2: Induction of the p55alpha
regulatory subunit of PI3-kinase and its role in survival of EREB2.
5 cells. J Gen Virol. 87:2859–2867. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Iida S, Rao PH, Butler M, Corradini P,
Boccadoro M, Klein B, Chaganti RS and Dalla-Favera R: Deregulation
of MUM1/IRF4 by chromosomal translocation in multiple myeloma. Nat
Genet. 17:226–230. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Mamane Y, Grandvaux N, Hernandez E, Sharma
S, Innocente SA, Lee JM, Azimi N, Lin R and Hiscott J: Repression
of IRF-4 target genes in human T cell leukemia virus-1 infection.
Oncogene. 21:6751–6765. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Sharma S, Mamane Y, Grandvaux N, Bartlett
J, Petropoulos L, Lin R and Hiscott J: Activation and regulation of
interferon regulatory factor 4 in HTLV type 1-infected T
lymphocytes. AIDS Res Hum Retroviruses. 16:1613–1622. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ortmann CA, Burchert A, Hölzle K, Nitsche
A, Wittig B, Neubauer A and Schmidt M: Down-regulation of
interferon regulatory factor 4 gene expression in leukemic cells
due to hypermethylation of CpG motifs in the promoter region.
Nucleic Acids Res. 33:6895–6905. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Schmidt M, Hochhaus A, König-Merediz SA,
Brendel C, Proba J, Hoppe GJ, Wittig B, Ehninger G, Hehlmann R and
Neubauer A: Expression of interferon regulatory factor 4 in chronic
myeloid leukemia: Correlation with response to interferon alfa
therapy. J Clin Oncol. 18:3331–3338. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Tsuboi K, Iida S, Inagaki H, Kato M,
Hayami Y, Hanamura I, Miura K, Harada S, Kikuchi M, Komatsu H, et
al: MUM 1/IRF4 expression as a frequent event in mature lymphoid
malignancies. Leukemia. 14:449–456. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Yang M, Yuan F, Li P, Chen Z, Chen A, Li S
and Hu C: Interferon regulatory factor 4 binding protein is a novel
p53 target gene and suppresses cisplatin-induced apoptosis of
breast cancer cells. Mol Cancer. 11:542012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Chen HY, Yu SL, Chen CH, Chang GC, Chen
CY, Yuan A, Cheng CL, Wang CH, Terng HJ, Kao SF, et al: A five-gene
signature and clinical outcome in non-small-cell lung cancer. N
Engl J Med. 356:11–20. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Blackman SC, Podtelezhnikov A, Railkar RA,
Loboda A, Tanis K, Klappenbach JA, Watters J, Iannone R, Herman G
and Bergtrom DA: Abstract 26: Notch pathway inhibition with MK-0752
leads to dose- and time-dependent transcriptional alterations in
proliferation, PI3K, and Wnt pathway genes in plucked human hair
follicles. Cancer Res. 70:17–21. 2010. View Article : Google Scholar
|
|
19
|
Zhao J and Lever AM: Lentivirus-mediated
gene expression. Methods Mol Biol. 366:343–355. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Harper JA, Yuan JS, Tan JB, Visan I and
Guidos CJ: Notch signaling in development and disease. Clin Genet.
64:461–472. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kadesch T: Notch signaling: The demise of
elegant simplicity. Curr Opin Genet Dev. 14:506–512. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ellisen LW, Bird J, West DC, Soreng AL,
Reynolds TC, Smith SD and Sklar J: TAN-1, the human homolog of the
Drosophila notch gene, is broken by chromosomal translocations in T
lymphoblastic neoplasms. Cell. 66:649–661. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Shukla V, Shukla A, Joshi SS and Lu R:
Interferon regulatory factor 4 attenuates Notch signaling to
suppress the development of chronic lymphocytic leukemia.
Oncotarget. 7:41081–41094. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhu H, Bhaijee F, Ishaq N, Pepper DJ,
Backus K, Brown AS, Zhou X and Miele L: Correlation of Notch1, pAKT
and nuclear NF-κB expression in triple negative breast cancer. Am J
Cancer Res. 3:230–239. 2013.PubMed/NCBI
|
|
25
|
Gualco G, Weiss LM and Bacchi CE:
MUM1/IRF4: A Review. Appl Immunohistochem Mol Morphol. 18:301–310.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Wu YY, Hwang YT, Perng WC, Chian CF, Ho
CL, Lee SC, Chang H, Terng HJ and Chao TY: CPEB4 and IRF4
expression in peripheral mononuclear cells are potential prognostic
factors for advanced lung cancer. J Formos Med Assoc. 116:114–122.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Artavanis-Tsakonas S, Rand MD and Lake RJ:
Notch signaling: Cell fate control and signal integration in
development. Science. 284:770–776. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Bray SJ: Notch signalling: A simple
pathway becomes complex. Nat Rev Mol Cell Biol. 7:678–689. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Weijzen S, Rizzo P, Braid M, Vaishnav R,
Jonkheer SM, Zlobin A, Osborne BA, Gottipati S, Aster JC, Hahn WC,
et al: Activation of Notch-1 signaling maintains the neoplastic
phenotype in human Ras-transformed cells. Nat Med. 8:979–986. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Allen TD, Rodriguez EM, Jones KD and
Bishop JM: Activated Notch1 induces lung adenomas in mice and
cooperates with Myc in the generation of lung adenocarcinoma.
Cancer Res. 71:6010–6018. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Osanyingbemi-Obidi J, Dobromilskaya I,
Illei PB, Hann CL and Rudin CM: Notch signaling contributes to lung
cancer clonogenic capacity in vitro but may be circumvented in
tumorigenesis in vivo. Mol Cancer Res. 9:1746–1754. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Baumgart A, Seidl S, Vlachou P, Michel L,
Mitova N, Schatz N, Specht K, Koch I, Schuster T, Grundler R, et
al: ADAM17 regulates epidermal growth factor receptor expression
through the activation of Notch1 in non-small cell lung cancer.
Cancer Res. 70:5368–5378. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Mimae T, Okada M, Hagiyama M, Miyata Y,
Tsutani Y, Inoue T, Murakami Y and Ito A: Upregulation of notch2
and six1 is associated with progression of early-stage lung
adenocarcinoma and a more aggressive phenotype at advanced stages.
Clin Cancer Res. 18:945–955. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Fan X, Mikolaenko I, Elhassan I, Ni X,
Wang Y, Ball D, Brat DJ, Perry A and Eberhart CG: Notch1 and notch2
have opposite effects on embryonal brain tumor growth. Cancer Res.
64:7787–7793. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Graziani I, Eliasz S, De Marco MA, Chen Y,
Pass HI, De May RM, Strack PR, Miele L and Bocchetta M: Opposite
effects of Notch-1 and Notch-2 on mesothelioma cell survival under
hypoxia are exerted through the Akt pathway. Cancer Res.
68:9678–9685. 2008. View Article : Google Scholar : PubMed/NCBI
|
